A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
This study is to evaluate the objective response rate to pralatrexate in Asian PTCL patients
after prior treatment failure, as determined by independent imaging reviewer(s) using
international workshop lymphoma response criteria (IWC)